UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Association of BCR/ABL transcript variants with different blood parameters and demographic features in Iraqi chronic myeloid leukemia patients

Molecular genetics & genomic medicine, 2019-08, Vol.7 (8), p.e809-n/a

2019

Volltextzugriff (PDF)

Electrochemical DNA biosensor for chronic myelocytic leukemia based on hybrid nanostructure

Bioelectrochemistry (Amsterdam, Netherlands), 2022-10, Vol.147, p.108176-108176, Article 108176

2022

Volltextzugriff (PDF)

Twins with different personalities: STAT5B-but not STAT5A-has a key role in BCR/ABL-induced leukemia

Leukemia, 2019-07, Vol.33 (7), p.1583-1597

2019

Volltextzugriff (PDF)

Efficient DNA Walker Guided with Well-Regulated Interfacial Tracks for Ultrasensitive Electrochemiluminescence Biosensing

Analytical chemistry (Washington), 2020-12, Vol.92 (23), p.15624-15631

2020

Volltextzugriff (PDF)

Dehydrocostus Lactone Suppresses Proliferation of Human Chronic Myeloid Leukemia Cells Through Bcr/Abl‐JAK/STAT Signaling Pathways

Journal of cellular biochemistry, 2017-10, Vol.118 (10), p.3381-3390

2017

Volltextzugriff (PDF)

The FABD domain is critical for the oncogenicity of BCR/ABL in chronic myeloid leukaemia

Cell communication and signaling, 2024-06, Vol.22 (1), p.314-13

2024

Volltextzugriff (PDF)

Droplet digital PCR for BCR/ABL(P210) detection of chronic myeloid leukemia: A high sensitive method of the minimal residual disease and disease progression

European journal of haematology, 2018-09, Vol.101 (3), p.291-296

2018

Volltextzugriff (PDF)

(−)‐Epigallocatechin‐3‐gallate induces cell apoptosis in chronic myeloid leukaemia by regulating Bcr/Abl‐mediated p38‐MAPK/JNK and JAK2/STAT3/AKT signalling pathways

Clinical and experimental pharmacology & physiology, 2019-02, Vol.46 (2), p.126-136

2019

Volltextzugriff (PDF)

MicroRNA-320a acts as a tumor suppressor by targeting BCR/ABL oncogene in chronic myeloid leukemia

Scientific reports, 2015-07, Vol.5, p.12460-12460

2015

Volltextzugriff (PDF)

Inhibition of LATS kinases reduces tumorigenicity and increases the sensitivity of human chronic myelogenous leukemia cells to imatinib

Scientific reports, 2024-02, Vol.14 (1), p.3993-3993, Article 3993

2024

Volltextzugriff (PDF)

Targeted therapies don't work for a reason; the neglected tumor suppressor phosphatase PP2A strikes back

The FEBS journal, 2018-11, Vol.285 (22), p.4139-4145

Westermarck, Jukka

2018

Volltextzugriff (PDF)

A new pre-emptive TKIs strategy for preventing relapse based on BCR/ABL monitoring for Ph+ALL undergoing allo-HCT: a prospective clinical cohort study

Leukemia, 2021-07, Vol.35 (7), p.2054-2063

2021

Volltextzugriff (PDF)

Subclones with the t(9;22)/BCR‐ABL1 rearrangement occur in AML and seem to cooperate with distinct genetic alterations

British journal of haematology, 2011-03, Vol.152 (6), p.713-720

2011

Volltextzugriff (PDF)

Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia

The New England journal of medicine, 2001-04, Vol.344 (14), p.1031-1037

2001

Volltextzugriff (PDF)

Combination of curaxin and tyrosine kinase inhibitors display enhanced killing of primitive Chronic Myeloid Leukaemia cells

PloS one, 2022-03, Vol.17 (3), p.e0266298-e0266298

2022

Volltextzugriff (PDF)

BCR/ABL-Positive Chronic Myeloid Leukemia in Children: Current Treatment Approach

Current oncology reports, 2024-03, Vol.26 (3), p.250-257

2024

Volltextzugriff (PDF)

Pathogenic Citrulline‐Multispecific B Cell Receptor Clades in Rheumatoid Arthritis

Arthritis & rheumatology (Hoboken, N.J.), 2018-12, Vol.70 (12), p.1933-1945

2018

Volltextzugriff (PDF)

Molecular Pathogenesis and Treatment Strategies of Chronic Myeloid Leukemia (CML)

Sudan journal of medical sciences, 2023-01

2023

Volltextzugriff (PDF)

Intracellular delivery of anti-BCR/ABL antibody by PLGA nanoparticles suppresses the oncogenesis of chronic myeloid leukemia cells

Journal of hematology and oncology, 2021-09, Vol.14 (1), p.139-18, Article 139

2021

Volltextzugriff (PDF)

Costunolide promotes imatinib‐induced apoptosis in chronic myeloid leukemia cells via the Bcr/Abl–Stat5 pathway

Phytotherapy research, 2018-09, Vol.32 (9), p.1764-1769

2018

Volltextzugriff (PDF)

Altered intracellular signaling by imatinib increases the anti‐cancer effects of tyrosine kinase inhibitors in chronic myelogenous leukemia cells

Cancer science, 2018-01, Vol.109 (1), p.121-131

2018

Volltextzugriff (PDF)

Evolution of BCR/ABL gene mutation in CML is time dependent and dependent on the pressure exerted by tyrosine kinase inhibitor

PloS one, 2015-01, Vol.10 (1), p.e0114828-e0114828

2015

Volltextzugriff (PDF)

Investigating the Activity of Indole-2-on Derivative Src Kinase Inhibitors Against Chronic Myeloid Leukemia Cells

Anti-cancer agents in medicinal chemistry, 2023, Vol.23 (1), p.113-122

2023

Volltextzugriff (PDF)

CRISPR/Cas9-Directed Gene Trap Constitutes a Selection System for Corrected BCR/ABL Leukemic Cells in CML

International journal of molecular sciences, 2022-06, Vol.23 (12), p.6386

2022

Volltextzugriff (PDF)

Stat5 is indispensable for the maintenance of bcr/abl‐positive leukaemia

EMBO molecular medicine, 2010-03, Vol.2 (3), p.98-110

2010

Volltextzugriff (PDF)

1 – 25 von 6.121

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(5.487)
Mit Volltextzugriff
(4.977)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

13 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(5.342)
Science & Technology
(5.053)
Life Sciences & Biomedicine
(4.762)
Leukemia, Myelogenous, Chronic, Bcr-Abl Positive - Genetics
(2.671)
Hematology
(2.491)
Oncology
(2.358)
Biological And Medical Sciences
(2.174)
Medical Sciences
(1.961)
Male
(1.922)
Female
(1.794)
Leukemia
(1.770)
Fusion Proteins, Bcr-Abl - Genetics
(1.685)
Adult
(1.574)
Chronic Myeloid Leukemia
(1.549)
Leukemia, Myelogenous, Chronic, Bcr-Abl Positive - Pathology
(1.482)
Middle Aged
(1.385)
Animals
(1.194)
Leukemia, Myelogenous, Chronic, Bcr-Abl Positive - Drug Therapy
(1.174)
Hematologic And Hematopoietic Diseases
(1.125)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(1.054)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(5.702)
EZB Electronic Journals Library
(3.843)
Ovid SocietyJournals and Single Titles
(2.526)
Ingenta Connect
(2.288)
NUS Single-Journal Subscriptions
(1.270)
Nature_系列刊
(1.205)
Nexis Uni
(1.148)
IngentaConnect Journals
(1.079)
Elsevier ScienceDirect Journals Complete
(876)
Wiley Online Library
(806)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(744)
Wiley Online Library Full Collection 2018
(667)
Springer journals
(485)
Taylor & Francis Journals Auto-Holdings Collection
(293)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(287)
Taylor & Francis
(273)
Taylor & Francis E-Journals
(241)
Oxford journals
(119)
JSTOR Complete Journals
(95)
Oxford Journals 2020 Medicine
(80)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(12)

Menü

Weitere Dienste

Einstellungen

Association of BCR/ABL transcript variants with different blood parameters and demographic features in Iraqi chronic myeloid leukemia patients

Electrochemical DNA biosensor for chronic myelocytic leukemia based on hybrid nanostructure

Twins with different personalities: STAT5B-but not STAT5A-has a key role in BCR/ABL-induced leukemia

Efficient DNA Walker Guided with Well-Regulated Interfacial Tracks for Ultrasensitive Electrochemiluminescence Biosensing

Dehydrocostus Lactone Suppresses Proliferation of Human Chronic Myeloid Leukemia Cells Through Bcr/Abl‐JAK/STAT Signaling Pathways

The FABD domain is critical for the oncogenicity of BCR/ABL in chronic myeloid leukaemia

Droplet digital PCR for BCR/ABL(P210) detection of chronic myeloid leukemia: A high sensitive method of the minimal residual disease and disease progression

(−)‐Epigallocatechin‐3‐gallate induces cell apoptosis in chronic myeloid leukaemia by regulating Bcr/Abl‐mediated p38‐MAPK/JNK and JAK2/STAT3/AKT signalling pathways

MicroRNA-320a acts as a tumor suppressor by targeting BCR/ABL oncogene in chronic myeloid leukemia

Inhibition of LATS kinases reduces tumorigenicity and increases the sensitivity of human chronic myelogenous leukemia cells to imatinib

Targeted therapies don't work for a reason; the neglected tumor suppressor phosphatase PP2A strikes back

A new pre-emptive TKIs strategy for preventing relapse based on BCR/ABL monitoring for Ph+ALL undergoing allo-HCT: a prospective clinical cohort study

Subclones with the t(9;22)/BCR‐ABL1 rearrangement occur in AML and seem to cooperate with distinct genetic alterations

Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia

Combination of curaxin and tyrosine kinase inhibitors display enhanced killing of primitive Chronic Myeloid Leukaemia cells

BCR/ABL-Positive Chronic Myeloid Leukemia in Children: Current Treatment Approach

Pathogenic Citrulline‐Multispecific B Cell Receptor Clades in Rheumatoid Arthritis

Molecular Pathogenesis and Treatment Strategies of Chronic Myeloid Leukemia (CML)

Intracellular delivery of anti-BCR/ABL antibody by PLGA nanoparticles suppresses the oncogenesis of chronic myeloid leukemia cells

Costunolide promotes imatinib‐induced apoptosis in chronic myeloid leukemia cells via the Bcr/Abl–Stat5 pathway

Altered intracellular signaling by imatinib increases the anti‐cancer effects of tyrosine kinase inhibitors in chronic myelogenous leukemia cells

Evolution of BCR/ABL gene mutation in CML is time dependent and dependent on the pressure exerted by tyrosine kinase inhibitor

Investigating the Activity of Indole-2-on Derivative Src Kinase Inhibitors Against Chronic Myeloid Leukemia Cells

CRISPR/Cas9-Directed Gene Trap Constitutes a Selection System for Corrected BCR/ABL Leukemic Cells in CML

Stat5 is indispensable for the maintenance of bcr/abl‐positive leukaemia

Suchergebnisse filtern